Form 8-K - Current report:
SEC Accession No. 0001104659-08-077293
Filing Date
2008-12-18
Accepted
2008-12-18 16:34:40
Documents
4
Period of Report
2008-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-30600_18k.htm 8-K 48637
2 EX-4.1 a08-30600_1ex4d1.htm EX-4.1 89206
3 EX-10.1 a08-30600_1ex10d1.htm EX-10.1 378983
4 EX-10.2 a08-30600_1ex10d2.htm EX-10.2 73961
  Complete submission text file 0001104659-08-077293.txt   592489
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 081257693
SIC: 2836 Biological Products, (No Diagnostic Substances)